Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Use of Naldemedine on Opioid-Induced Nausea and Vomiting in Patients With Cancer: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

NCT07038551 is registered in ClinicalTrials.gov with International University of Health and Welfare as lead sponsor.

NCT NCT07038551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07038551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Use of Naldemedine on Opioid-Induced Nausea and Vomiting in Patients With Cancer: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
Lead sponsor
International University of Health and Welfare
Phase
Phase 4
Overall status
Completed
Start date
June 20, 2025
Completion date
February 13, 2026
Enrollment
120 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-induced nausea and vomitting(oinv)